Steven Barger
Concepts (336)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 13 | 2024 | 367 | 3.390 |
Why?
| Glutamic Acid | 11 | 2023 | 111 | 2.670 |
Why?
| Microglia | 13 | 2023 | 137 | 2.610 |
Why?
| Amyloid beta-Peptides | 5 | 2023 | 82 | 2.360 |
Why?
| Brain | 17 | 2022 | 1387 | 2.300 |
Why?
| Neurons | 15 | 2018 | 486 | 2.070 |
Why?
| Gene Expression Regulation | 10 | 2016 | 1062 | 1.910 |
Why?
| Amyloid beta-Protein Precursor | 8 | 2018 | 33 | 1.860 |
Why?
| Racemases and Epimerases | 8 | 2012 | 15 | 1.570 |
Why?
| NF-kappa B | 6 | 2016 | 335 | 1.560 |
Why?
| Apolipoproteins E | 5 | 2023 | 62 | 1.440 |
Why?
| Animals | 45 | 2024 | 14385 | 1.110 |
Why?
| Serine | 9 | 2022 | 44 | 1.090 |
Why?
| Astrocytes | 4 | 2020 | 142 | 1.040 |
Why?
| Cells, Cultured | 19 | 2016 | 1737 | 0.950 |
Why?
| Mice, Transgenic | 9 | 2023 | 656 | 0.930 |
Why?
| Insulin | 3 | 2020 | 510 | 0.840 |
Why?
| Peptide Fragments | 3 | 2020 | 242 | 0.830 |
Why?
| Glucose Transporter Type 1 | 1 | 2020 | 16 | 0.780 |
Why?
| Rats | 17 | 2016 | 3415 | 0.700 |
Why?
| Transcription Factor AP-1 | 2 | 2012 | 64 | 0.680 |
Why?
| Phosphatidylinositol Phosphates | 1 | 2018 | 15 | 0.670 |
Why?
| Somatomedins | 1 | 2018 | 29 | 0.670 |
Why?
| Blood Glucose | 2 | 2020 | 489 | 0.630 |
Why?
| Membrane Proteins | 4 | 2018 | 389 | 0.620 |
Why?
| Gene Expression | 4 | 2020 | 664 | 0.610 |
Why?
| Central Nervous System | 2 | 2016 | 85 | 0.600 |
Why?
| Rats, Sprague-Dawley | 12 | 2019 | 1663 | 0.600 |
Why?
| Neurochemistry | 1 | 2016 | 3 | 0.590 |
Why?
| Diet, High-Fat | 2 | 2018 | 216 | 0.590 |
Why?
| LDL-Receptor Related Proteins | 1 | 2016 | 11 | 0.590 |
Why?
| Presenilin-1 | 1 | 2016 | 16 | 0.590 |
Why?
| Nerve Tissue Proteins | 3 | 2023 | 199 | 0.590 |
Why?
| Interleukin-1beta | 2 | 2019 | 92 | 0.570 |
Why?
| Transcription, Genetic | 2 | 2009 | 418 | 0.560 |
Why?
| Obesity | 3 | 2020 | 1202 | 0.550 |
Why?
| Genetic Therapy | 1 | 2016 | 121 | 0.550 |
Why?
| Neuroglia | 2 | 2012 | 52 | 0.530 |
Why?
| Receptors, N-Methyl-D-Aspartate | 3 | 2022 | 121 | 0.520 |
Why?
| Neuroprotective Agents | 3 | 2007 | 125 | 0.520 |
Why?
| Mice | 19 | 2024 | 6413 | 0.510 |
Why?
| Neurodegenerative Diseases | 2 | 2007 | 83 | 0.510 |
Why?
| Animals, Newborn | 8 | 2014 | 396 | 0.510 |
Why?
| Sp1 Transcription Factor | 3 | 2009 | 18 | 0.490 |
Why?
| Inflammation | 4 | 2011 | 674 | 0.480 |
Why?
| DNA Methylation | 1 | 2018 | 574 | 0.470 |
Why?
| Frontotemporal Dementia | 1 | 2013 | 4 | 0.470 |
Why?
| Superoxide Dismutase | 3 | 2012 | 125 | 0.460 |
Why?
| Epigenesis, Genetic | 1 | 2016 | 399 | 0.450 |
Why?
| Apolipoprotein E4 | 3 | 2024 | 19 | 0.450 |
Why?
| Presynaptic Terminals | 1 | 2012 | 13 | 0.450 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2012 | 14 | 0.440 |
Why?
| Glycogen Synthase Kinase 3 | 2 | 2015 | 21 | 0.440 |
Why?
| Humans | 30 | 2023 | 54284 | 0.440 |
Why?
| Mutation | 3 | 2016 | 1501 | 0.430 |
Why?
| Interleukin-1alpha | 1 | 2012 | 13 | 0.430 |
Why?
| Cytokines | 3 | 2017 | 676 | 0.430 |
Why?
| Reactive Nitrogen Species | 1 | 2012 | 37 | 0.420 |
Why?
| Oxidation-Reduction | 3 | 2011 | 382 | 0.420 |
Why?
| Cysteine | 1 | 2011 | 62 | 0.410 |
Why?
| Promoter Regions, Genetic | 2 | 2012 | 520 | 0.400 |
Why?
| Polymorphism, Genetic | 1 | 2012 | 193 | 0.400 |
Why?
| Signal Transduction | 7 | 2023 | 1753 | 0.400 |
Why?
| Sp4 Transcription Factor | 2 | 2009 | 3 | 0.390 |
Why?
| Neuronal Plasticity | 2 | 2016 | 58 | 0.390 |
Why?
| Hippocampus | 3 | 2018 | 242 | 0.380 |
Why?
| Dose-Response Relationship, Drug | 7 | 2015 | 1476 | 0.380 |
Why?
| Reactive Oxygen Species | 2 | 2013 | 491 | 0.380 |
Why?
| RNA, Small Interfering | 4 | 2016 | 252 | 0.370 |
Why?
| Extracellular Matrix Proteins | 2 | 2023 | 75 | 0.370 |
Why?
| Serine Endopeptidases | 2 | 2023 | 57 | 0.370 |
Why?
| Aging | 3 | 2022 | 784 | 0.340 |
Why?
| Lipopolysaccharides | 5 | 2012 | 199 | 0.340 |
Why?
| Drug Interactions | 4 | 2012 | 206 | 0.340 |
Why?
| RNA, Messenger | 9 | 2018 | 1202 | 0.330 |
Why?
| Plaque, Amyloid | 1 | 2008 | 17 | 0.330 |
Why?
| Schwann Cells | 2 | 2005 | 14 | 0.330 |
Why?
| Interleukin-1 | 2 | 2005 | 107 | 0.310 |
Why?
| Cystine | 2 | 2023 | 15 | 0.300 |
Why?
| Sp3 Transcription Factor | 1 | 2007 | 4 | 0.300 |
Why?
| Receptors, Glutamate | 1 | 2007 | 11 | 0.300 |
Why?
| Lithium Chloride | 1 | 2007 | 6 | 0.300 |
Why?
| Transcription Factors | 2 | 2016 | 622 | 0.300 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2007 | 23 | 0.300 |
Why?
| Calpain | 1 | 2007 | 28 | 0.300 |
Why?
| Male | 13 | 2023 | 27334 | 0.290 |
Why?
| Lipid Peroxidation | 1 | 2007 | 132 | 0.290 |
Why?
| Neurobiology | 1 | 2006 | 5 | 0.280 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 78 | 0.280 |
Why?
| Nerve Growth Factors | 2 | 2006 | 32 | 0.280 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2006 | 151 | 0.280 |
Why?
| Electrophoretic Mobility Shift Assay | 4 | 2017 | 74 | 0.270 |
Why?
| Apolipoprotein E3 | 2 | 2023 | 8 | 0.270 |
Why?
| Kynurenic Acid | 1 | 2005 | 4 | 0.260 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2005 | 99 | 0.260 |
Why?
| Amyloid Precursor Protein Secretases | 2 | 2016 | 14 | 0.260 |
Why?
| Amino Acid Isomerases | 1 | 2004 | 4 | 0.260 |
Why?
| Intellectual Property | 1 | 2004 | 4 | 0.260 |
Why?
| S100 Proteins | 1 | 2005 | 41 | 0.260 |
Why?
| Cognition | 2 | 2023 | 348 | 0.250 |
Why?
| Research Support as Topic | 1 | 2004 | 51 | 0.250 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 673 | 0.240 |
Why?
| Antiporters | 1 | 2023 | 19 | 0.240 |
Why?
| Genotype | 2 | 2023 | 599 | 0.240 |
Why?
| Embryo, Mammalian | 3 | 2016 | 68 | 0.230 |
Why?
| Blotting, Western | 4 | 2013 | 683 | 0.230 |
Why?
| tau Proteins | 3 | 2016 | 30 | 0.230 |
Why?
| Transcription Factor RelA | 2 | 2016 | 30 | 0.230 |
Why?
| Cerebral Cortex | 5 | 2013 | 234 | 0.230 |
Why?
| Cooperative Behavior | 1 | 2004 | 254 | 0.220 |
Why?
| Protein Binding | 4 | 2017 | 736 | 0.220 |
Why?
| Female | 10 | 2023 | 28441 | 0.220 |
Why?
| Enzyme Inhibitors | 4 | 2012 | 446 | 0.210 |
Why?
| N-Methylaspartate | 1 | 2022 | 27 | 0.210 |
Why?
| Caenorhabditis elegans | 2 | 2024 | 146 | 0.210 |
Why?
| Mice, Inbred C57BL | 5 | 2016 | 1999 | 0.210 |
Why?
| Lysosomes | 2 | 2024 | 91 | 0.210 |
Why?
| Cell Adhesion Molecules, Neuronal | 2 | 2023 | 9 | 0.210 |
Why?
| Oxygen | 1 | 2004 | 361 | 0.200 |
Why?
| Glucose | 1 | 2023 | 366 | 0.190 |
Why?
| Autophagy | 2 | 2024 | 202 | 0.180 |
Why?
| Fluorescent Antibody Technique | 3 | 2011 | 141 | 0.180 |
Why?
| Analysis of Variance | 3 | 2013 | 635 | 0.180 |
Why?
| Ubiquitination | 1 | 2019 | 47 | 0.180 |
Why?
| Risk | 1 | 2020 | 343 | 0.180 |
Why?
| Nitrites | 2 | 2012 | 39 | 0.170 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2019 | 99 | 0.170 |
Why?
| Insulysin | 1 | 2018 | 1 | 0.170 |
Why?
| Animals, Genetically Modified | 1 | 2018 | 52 | 0.170 |
Why?
| Models, Biological | 3 | 2007 | 823 | 0.170 |
Why?
| Proteomics | 2 | 2018 | 343 | 0.160 |
Why?
| Carbon | 1 | 2018 | 61 | 0.160 |
Why?
| Nucleotide Motifs | 1 | 2017 | 29 | 0.160 |
Why?
| D-Amino-Acid Oxidase | 2 | 2008 | 2 | 0.150 |
Why?
| Carrier Proteins | 1 | 2018 | 359 | 0.140 |
Why?
| Cell Line, Transformed | 2 | 2017 | 88 | 0.140 |
Why?
| TNF Receptor-Associated Factor 2 | 1 | 2016 | 4 | 0.140 |
Why?
| TNF Receptor-Associated Factor 6 | 1 | 2016 | 7 | 0.140 |
Why?
| Glycoside Hydrolases | 1 | 2016 | 27 | 0.140 |
Why?
| I-kappa B Kinase | 1 | 2016 | 29 | 0.140 |
Why?
| Disease Models, Animal | 4 | 2023 | 1639 | 0.140 |
Why?
| Autoradiography | 1 | 2016 | 36 | 0.140 |
Why?
| Insulin Resistance | 1 | 2018 | 300 | 0.140 |
Why?
| Forecasting | 1 | 2016 | 161 | 0.140 |
Why?
| Blood-Brain Barrier | 1 | 2016 | 59 | 0.140 |
Why?
| Transfection | 2 | 2007 | 399 | 0.130 |
Why?
| Anthracenes | 2 | 2005 | 13 | 0.130 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 314 | 0.130 |
Why?
| RNA Interference | 2 | 2013 | 195 | 0.130 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 206 | 0.130 |
Why?
| Calnexin | 1 | 2014 | 4 | 0.130 |
Why?
| Calreticulin | 1 | 2014 | 12 | 0.120 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 486 | 0.120 |
Why?
| Luciferases | 2 | 2023 | 57 | 0.120 |
Why?
| Cell Death | 3 | 2016 | 223 | 0.120 |
Why?
| Social Behavior Disorders | 1 | 2013 | 7 | 0.120 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2013 | 37 | 0.120 |
Why?
| Neocortex | 2 | 2014 | 8 | 0.120 |
Why?
| Proteasome Inhibitors | 1 | 2014 | 110 | 0.110 |
Why?
| Superoxides | 1 | 2013 | 61 | 0.110 |
Why?
| Neural Stem Cells | 1 | 2013 | 27 | 0.110 |
Why?
| 1-Methyl-3-isobutylxanthine | 1 | 2012 | 9 | 0.110 |
Why?
| Excitatory Amino Acid Agents | 1 | 2012 | 3 | 0.110 |
Why?
| Phosphorylation | 4 | 2018 | 614 | 0.110 |
Why?
| Dioxolanes | 1 | 2012 | 13 | 0.110 |
Why?
| Muscle, Skeletal | 1 | 2018 | 847 | 0.110 |
Why?
| 3-Mercaptopropionic Acid | 1 | 2012 | 1 | 0.110 |
Why?
| Spermine | 1 | 2012 | 4 | 0.110 |
Why?
| Hypoxanthine | 1 | 2012 | 4 | 0.110 |
Why?
| Pentetic Acid | 1 | 2012 | 6 | 0.110 |
Why?
| Sodium Dodecyl Sulfate | 1 | 2012 | 7 | 0.110 |
Why?
| Nitric Oxide Donors | 1 | 2012 | 12 | 0.110 |
Why?
| Hydroxyl Radical | 1 | 2012 | 10 | 0.110 |
Why?
| Pentaerythritol Tetranitrate | 1 | 2012 | 6 | 0.110 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 56 | 0.110 |
Why?
| Purines | 1 | 2012 | 45 | 0.110 |
Why?
| Chelating Agents | 1 | 2012 | 28 | 0.110 |
Why?
| Liver | 1 | 2018 | 1225 | 0.110 |
Why?
| Angiotensin II | 1 | 2013 | 166 | 0.100 |
Why?
| Protein Structure, Quaternary | 1 | 2011 | 28 | 0.100 |
Why?
| Peroxynitrous Acid | 1 | 2012 | 51 | 0.100 |
Why?
| Oxidants | 1 | 2012 | 64 | 0.100 |
Why?
| Protein Multimerization | 1 | 2011 | 54 | 0.100 |
Why?
| Hydrogen Peroxide | 1 | 2012 | 142 | 0.100 |
Why?
| Diabetic Retinopathy | 1 | 2011 | 41 | 0.100 |
Why?
| Retina | 1 | 2011 | 64 | 0.100 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2012 | 64 | 0.100 |
Why?
| Mass Spectrometry | 1 | 2012 | 313 | 0.090 |
Why?
| Cell Line | 3 | 2018 | 1153 | 0.090 |
Why?
| Pregnancy | 1 | 2018 | 2620 | 0.090 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2011 | 140 | 0.090 |
Why?
| Kinetics | 1 | 2011 | 692 | 0.090 |
Why?
| Recombinant Proteins | 1 | 2011 | 569 | 0.090 |
Why?
| Amino Acids | 1 | 2012 | 369 | 0.090 |
Why?
| Neurogenic Inflammation | 1 | 2009 | 4 | 0.090 |
Why?
| Prosencephalon | 1 | 2009 | 13 | 0.090 |
Why?
| I-kappa B Proteins | 1 | 2009 | 26 | 0.090 |
Why?
| Neurogenesis | 1 | 2009 | 30 | 0.090 |
Why?
| Reversal Learning | 1 | 2008 | 9 | 0.090 |
Why?
| Disease Susceptibility | 1 | 2009 | 95 | 0.090 |
Why?
| Extinction, Psychological | 1 | 2008 | 28 | 0.080 |
Why?
| Cell Proliferation | 1 | 2013 | 1096 | 0.080 |
Why?
| Time Factors | 2 | 2005 | 3213 | 0.080 |
Why?
| Acetophenones | 1 | 2007 | 13 | 0.080 |
Why?
| Onium Compounds | 1 | 2007 | 14 | 0.080 |
Why?
| Butadienes | 2 | 2005 | 50 | 0.080 |
Why?
| Nitriles | 2 | 2005 | 69 | 0.080 |
Why?
| Schizophrenia | 1 | 2009 | 276 | 0.080 |
Why?
| Models, Molecular | 2 | 2019 | 423 | 0.080 |
Why?
| Sp Transcription Factors | 1 | 2006 | 6 | 0.070 |
Why?
| HIV | 1 | 2006 | 26 | 0.070 |
Why?
| Ischemic Attack, Transient | 1 | 2007 | 60 | 0.070 |
Why?
| alpha-Synuclein | 1 | 2006 | 13 | 0.070 |
Why?
| Immunoglobulins | 1 | 2006 | 89 | 0.070 |
Why?
| Vitamin E | 1 | 2007 | 107 | 0.070 |
Why?
| Cell Nucleus | 1 | 2006 | 203 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2007 | 377 | 0.070 |
Why?
| Reperfusion Injury | 1 | 2007 | 118 | 0.070 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2003 | 169 | 0.070 |
Why?
| 2-Amino-5-phosphonovalerate | 1 | 2005 | 7 | 0.070 |
Why?
| Tetrazolium Salts | 1 | 2005 | 17 | 0.070 |
Why?
| Culture Media, Conditioned | 1 | 2005 | 52 | 0.070 |
Why?
| Nerve Degeneration | 1 | 2005 | 33 | 0.070 |
Why?
| Bone Marrow Cells | 1 | 2006 | 233 | 0.060 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2005 | 51 | 0.060 |
Why?
| Thiazoles | 1 | 2005 | 61 | 0.060 |
Why?
| Respiratory Burst | 1 | 2004 | 4 | 0.060 |
Why?
| Glutamates | 1 | 2004 | 22 | 0.060 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 78 | 0.060 |
Why?
| Drug Combinations | 1 | 2005 | 128 | 0.060 |
Why?
| Antioxidants | 1 | 2007 | 297 | 0.060 |
Why?
| Cloning, Molecular | 1 | 2004 | 198 | 0.060 |
Why?
| Age Factors | 1 | 2008 | 1198 | 0.060 |
Why?
| Mutagenesis | 1 | 2004 | 77 | 0.060 |
Why?
| Sciatic Nerve | 1 | 2004 | 32 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 101 | 0.060 |
Why?
| Stem Cells | 1 | 2006 | 193 | 0.060 |
Why?
| Receptors, Lipoprotein | 1 | 2004 | 8 | 0.060 |
Why?
| Adaptation, Physiological | 1 | 2004 | 101 | 0.060 |
Why?
| Memory | 1 | 2005 | 124 | 0.060 |
Why?
| Receptors, Immunologic | 1 | 2004 | 37 | 0.060 |
Why?
| Imidazoles | 1 | 2005 | 142 | 0.060 |
Why?
| Pyridines | 1 | 2005 | 137 | 0.060 |
Why?
| Synaptophysin | 1 | 2003 | 9 | 0.060 |
Why?
| Anti-Inflammatory Agents | 1 | 2004 | 175 | 0.060 |
Why?
| Receptors, LDL | 1 | 2023 | 70 | 0.060 |
Why?
| Case-Control Studies | 3 | 2016 | 1228 | 0.060 |
Why?
| Mice, Knockout | 2 | 2018 | 926 | 0.060 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2002 | 15 | 0.060 |
Why?
| Learning | 1 | 2005 | 175 | 0.060 |
Why?
| Lipoprotein Lipase | 1 | 2002 | 15 | 0.060 |
Why?
| Calcium | 1 | 2005 | 432 | 0.050 |
Why?
| HEK293 Cells | 1 | 2023 | 245 | 0.050 |
Why?
| Protein Kinase C | 1 | 2002 | 65 | 0.050 |
Why?
| Dexamethasone | 1 | 2004 | 435 | 0.050 |
Why?
| Fibroblasts | 1 | 2004 | 386 | 0.050 |
Why?
| Isoenzymes | 1 | 2002 | 177 | 0.050 |
Why?
| Disease Progression | 2 | 2017 | 913 | 0.050 |
Why?
| Adipocytes | 1 | 2002 | 129 | 0.050 |
Why?
| Aged | 2 | 2019 | 10054 | 0.050 |
Why?
| Aged, 80 and over | 1 | 2008 | 3431 | 0.050 |
Why?
| DNA | 1 | 2004 | 581 | 0.050 |
Why?
| Ubiquitin | 1 | 2019 | 51 | 0.050 |
Why?
| Protein Transport | 1 | 2019 | 195 | 0.040 |
Why?
| Enzyme Activation | 1 | 2019 | 329 | 0.040 |
Why?
| Synaptosomes | 1 | 2018 | 13 | 0.040 |
Why?
| Glucose Intolerance | 1 | 2018 | 28 | 0.040 |
Why?
| Oxidative Stress | 1 | 2004 | 958 | 0.040 |
Why?
| Receptor, Insulin | 1 | 2018 | 44 | 0.040 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 14 | 0.040 |
Why?
| Epistasis, Genetic | 1 | 2017 | 42 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2017 | 83 | 0.040 |
Why?
| Cell Differentiation | 2 | 2013 | 720 | 0.040 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.040 |
Why?
| Detergents | 1 | 2016 | 17 | 0.040 |
Why?
| 14-3-3 Proteins | 1 | 2016 | 24 | 0.040 |
Why?
| Solubility | 1 | 2016 | 75 | 0.040 |
Why?
| Computer Simulation | 1 | 2017 | 332 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 125 | 0.040 |
Why?
| Risk Factors | 1 | 2004 | 3935 | 0.030 |
Why?
| Oxidopamine | 1 | 2014 | 4 | 0.030 |
Why?
| Brefeldin A | 1 | 2014 | 19 | 0.030 |
Why?
| Protein Disulfide-Isomerases | 1 | 2014 | 15 | 0.030 |
Why?
| Adrenergic Agents | 1 | 2014 | 17 | 0.030 |
Why?
| Antibodies | 2 | 2006 | 178 | 0.030 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2014 | 42 | 0.030 |
Why?
| Receptor, Notch1 | 1 | 2013 | 4 | 0.030 |
Why?
| Cytokine Receptor gp130 | 1 | 2013 | 13 | 0.030 |
Why?
| Exploratory Behavior | 1 | 2013 | 39 | 0.030 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 123 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2013 | 110 | 0.030 |
Why?
| Psychomotor Agitation | 1 | 2013 | 53 | 0.030 |
Why?
| Cell Count | 1 | 2013 | 181 | 0.030 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 122 | 0.030 |
Why?
| Middle Aged | 1 | 2008 | 13088 | 0.030 |
Why?
| Interpersonal Relations | 1 | 2013 | 117 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 2013 | 177 | 0.030 |
Why?
| Adult | 1 | 2008 | 14207 | 0.030 |
Why?
| Streptozocin | 1 | 2011 | 27 | 0.030 |
Why?
| Aqueous Humor | 1 | 2011 | 11 | 0.030 |
Why?
| Parkinson Disease | 1 | 2014 | 180 | 0.030 |
Why?
| Interleukin-6 | 1 | 2013 | 315 | 0.030 |
Why?
| Autistic Disorder | 1 | 2013 | 135 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2015 | 1550 | 0.020 |
Why?
| Random Allocation | 1 | 2011 | 312 | 0.020 |
Why?
| Up-Regulation | 1 | 2012 | 508 | 0.020 |
Why?
| Pedigree | 1 | 2009 | 146 | 0.020 |
Why?
| Body Weight | 1 | 2011 | 578 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2009 | 198 | 0.020 |
Why?
| Maze Learning | 1 | 2008 | 55 | 0.020 |
Why?
| Peripheral Nervous System | 1 | 2004 | 18 | 0.020 |
Why?
| Child, Preschool | 1 | 2013 | 4147 | 0.020 |
Why?
| Scavenger Receptors, Class B | 1 | 2004 | 10 | 0.020 |
Why?
| Phagocytes | 1 | 2004 | 11 | 0.020 |
Why?
| Blotting, Northern | 1 | 2004 | 108 | 0.020 |
Why?
| Receptors, Scavenger | 1 | 2004 | 28 | 0.020 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 64 | 0.020 |
Why?
| Polysaccharides | 1 | 2004 | 57 | 0.010 |
Why?
| Biological Transport | 1 | 2004 | 195 | 0.010 |
Why?
| Sialoglycoproteins | 1 | 2003 | 9 | 0.010 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2003 | 12 | 0.010 |
Why?
| Interferon-gamma | 1 | 2004 | 195 | 0.010 |
Why?
| Polyribosomes | 1 | 2002 | 8 | 0.010 |
Why?
| Protein Kinase C-alpha | 1 | 2002 | 11 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2006 | 1089 | 0.010 |
Why?
| Coculture Techniques | 1 | 2003 | 160 | 0.010 |
Why?
| Cell Communication | 1 | 2003 | 72 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2002 | 47 | 0.010 |
Why?
| Phenotype | 1 | 2006 | 820 | 0.010 |
Why?
| Oligonucleotides, Antisense | 1 | 2002 | 29 | 0.010 |
Why?
| MAP Kinase Signaling System | 1 | 2002 | 133 | 0.010 |
Why?
| Flow Cytometry | 1 | 2004 | 546 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2003 | 434 | 0.010 |
Why?
| Child | 1 | 2013 | 7341 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2002 | 273 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2004 | 1300 | 0.010 |
Why?
|
|
Barger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|